BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 21890156)

  • 41. Aquaporin-4 autoantibodies in a paraneoplastic context.
    Pittock SJ; Lennon VA
    Arch Neurol; 2008 May; 65(5):629-32. PubMed ID: 18474738
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Paraneoplastic immune-mediated neurological effects of systemic cancers.
    Sioka C; Fotopoulos A; Kyritsis AP
    Expert Rev Clin Immunol; 2014 May; 10(5):621-30. PubMed ID: 24665890
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Onconeural antibodies as a tool for diagnosis of malignant tumors and paraneoplastic neurological disorders].
    Belousov PV; Shebzukhov IuV; Nedospasov SA; Kuprash DV
    Mol Gen Mikrobiol Virusol; 2007; (2):6-13. PubMed ID: 17598451
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autoimmune channelopathies in paraneoplastic neurological syndromes.
    Joubert B; Honnorat J
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2665-76. PubMed ID: 25883091
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnosis and treatment of paraneoplastic neurological syndromes.
    Vitaliani R; Zoccarato M; Giometto B
    Curr Clin Pharmacol; 2008 Jan; 3(1):46-50. PubMed ID: 18690877
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Paraneoplastic neurologic syndromes: approaches to diagnosis and treatment.
    Bataller L; Dalmau J
    Semin Neurol; 2003 Jun; 23(2):215-24. PubMed ID: 12894387
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Autoantibodies in Paraneoplastic Neurological Syndrome].
    Kawachi I
    Brain Nerve; 2018 Apr; 70(4):329-339. PubMed ID: 29632281
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Paraneoplastic disorders of the peripheral nervous system.
    Antoine JC; Camdessanché JP
    Presse Med; 2013 Jun; 42(6 Pt 2):e235-44. PubMed ID: 23608019
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical analysis of anti-Ma2-associated encephalitis.
    Dalmau J; Graus F; Villarejo A; Posner JB; Blumenthal D; Thiessen B; Saiz A; Meneses P; Rosenfeld MR
    Brain; 2004 Aug; 127(Pt 8):1831-44. PubMed ID: 15215214
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Paraneoplastic neurological syndromes with reference to anti-neuronal autoantibodies].
    Tanaka K
    Rinsho Shinkeigaku; 2010 Jun; 50(6):371-8. PubMed ID: 20593661
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Autoimmune paraneoplastic neurological syndromes].
    Lövblad KO; Steck AJ
    Schweiz Rundsch Med Prax; 1992 Nov; 81(48):1455-7. PubMed ID: 1448641
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Paraneoplastic syndromes: a review].
    Berardi R; Grilli G; Romagnoli E; Saladino T; Freddari F; Tamburrano T; Galizia E; Carbonari G; Mariani C; Braconi C; Pierantoni C; Battelli N; Scartozzi M; Cascinu S
    Clin Ter; 2005; 156(6):281-8. PubMed ID: 16463565
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immune-mediated encephalopathies with an emphasis on paraneoplastic encephalopathies.
    Pruitt AA
    Semin Neurol; 2011 Apr; 31(2):158-68. PubMed ID: 21590621
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Paraneoplastic encephalomyelopathies: pathology and mechanisms.
    McKeon A; Pittock SJ
    Acta Neuropathol; 2011 Oct; 122(4):381-400. PubMed ID: 21938556
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Advances in paraneoplastic neurological syndromes.
    Honnorat J; Cartalat-Carel S
    Curr Opin Oncol; 2004 Nov; 16(6):614-20. PubMed ID: 15627026
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Paraneoplastic neurological syndromes].
    Storstein A; Vedeler CA
    Tidsskr Nor Laegeforen; 2009 Mar; 129(6):524-8. PubMed ID: 19282889
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pathogenesis, diagnosis and treatment of paraneoplastic neurologic syndromes.
    Blaes F
    Expert Rev Neurother; 2021 Jun; 21(6):675-686. PubMed ID: 33960258
    [No Abstract]   [Full Text] [Related]  

  • 58. Paraneoplastic disorders of the central nervous system: update on diagnostic criteria and treatment.
    Bataller L; Dalmau JO
    Semin Neurol; 2004 Dec; 24(4):461-71. PubMed ID: 15637657
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Which antibody and which cancer in which paraneoplastic syndromes?
    Gozzard P; Maddison P
    Pract Neurol; 2010 Oct; 10(5):260-70. PubMed ID: 20858627
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Paraneoplastic syndromes].
    Krome S
    Dtsch Med Wochenschr; 2012 Mar; 137 Suppl 1():S20-2. PubMed ID: 22438119
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.